Literature DB >> 31175465

Theoretical explanation for the pharmaceutical incompatibility through the cooperativity effect of the drug-drug intermolecular interactions in the phenobarbital∙∙∙paracetamol∙∙∙H2O complex.

Fei-Peng Zhai1, Hong-En Wei2, Yi Liu2, Feng-Yun Hu2.   

Abstract

In order to reveal the essence of the pharmaceutical incompatibility, the cooperativity effects of the drug-drug intermolecular π∙∙∙π and H∙∙∙O H-bonding interactions involving hydration were evaluated in the phenobarbital∙∙∙paracetamol∙∙∙H2O complex at the M06-2X/6-311++G** and MP2/6-311++G** levels. The thermodynamic cooperativity effects were also investigated by the statistical thermodynamic method. The results show that the π∙∙∙π stacking ternary complexes with the moderate anti-cooperativity effects are dominant in controling the aggregation process of phenobarbital, paracetamol, and H2O, as is confirmed by the atoms-in-molecules (AIM) and reduced density gradient (RDG) analyses. Therefore, it can be inferred that the anti-cooperativity effect plays an important role in forming the pharmaceutical incompatibility, and thus a deduction on the formation process of the pharmaceutical incompatibility between phenobarbital and paracetamol, with the hydration effect, is given. Several valuable models that relate the features of molecular surface electrostatic potentials or their statistical parameters, such as the surface areas, average values ([Formula: see text]), variances ([Formula: see text], [Formula: see text] and [Formula: see text]), and product of [Formula: see text] and electrostatic balance parameter (ν) ([Formula: see text]ν), to the values of the cooperativity effects were predicted. The formation of the pharmaceutical incompatibility is a thermodynamic cooperativity process driven by the enthalpy change. Graphical abstract Anti-cooperativity effect plays an important role in forming the pharmaceutical incompatibility.

Entities:  

Keywords:  Cooperativity effect; Pharmaceutical incompatibility; RDG; Surface electrostatic potential; π∙∙∙π

Mesh:

Substances:

Year:  2019        PMID: 31175465     DOI: 10.1007/s00894-019-4060-1

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  46 in total

1.  An enthalpic component in cooperativity: the relationship between enthalpy, entropy, and noncovalent structure in weak associations.

Authors:  C T Calderone; D H Williams
Journal:  J Am Chem Soc       Date:  2001-07-04       Impact factor: 15.419

2.  Hydration, stability, and phase transformations of a new antitumor drug.

Authors:  A Marini; V Berbenni; G Bruni; P Cofrancesco; C Margheritis; A Orlandi; M Villa
Journal:  J Pharm Sci       Date:  2004-09       Impact factor: 3.534

Review 3.  Understanding noncovalent interactions: ligand binding energy and catalytic efficiency from ligand-induced reductions in motion within receptors and enzymes.

Authors:  Dudley H Williams; Elaine Stephens; Dominic P O'Brien; Min Zhou
Journal:  Angew Chem Int Ed Engl       Date:  2004-12-10       Impact factor: 15.336

4.  Interaction energy contributions of H-bonded and stacked structures of the AT and GC DNA base pairs from the combined density functional theory and intermolecular perturbation theory approach.

Authors:  Andreas Hesselmann; Georg Jansen; Martin Schütz
Journal:  J Am Chem Soc       Date:  2006-09-13       Impact factor: 15.419

5.  A strategy for predicting the crystal structures of flexible molecules: the polymorphism of phenobarbital.

Authors:  G M Day; W D S Motherwell; W Jones
Journal:  Phys Chem Chem Phys       Date:  2007-01-24       Impact factor: 3.676

Review 6.  Doxorubicin and mechanical performance of cardiac trabeculae after acute and chronic treatment: a review.

Authors:  E L De Beer; A E Bottone; E E Voest
Journal:  Eur J Pharmacol       Date:  2001-03-09       Impact factor: 4.432

Review 7.  Cytochrome P-450 3A4: regulation and role in drug metabolism.

Authors:  F P Guengerich
Journal:  Annu Rev Pharmacol Toxicol       Date:  1999       Impact factor: 13.820

8.  Phenylalanine and tryptophan scanning mutagenesis of CYP3A4 substrate recognition site residues and effect on substrate oxidation and cooperativity.

Authors:  T L Domanski; Y A He; K K Khan; F Roussel; Q Wang; J R Halpert
Journal:  Biochemistry       Date:  2001-08-28       Impact factor: 3.162

9.  Application of on-line Raman spectroscopy for characterizing relationships between drug hydration state and tablet physical stability.

Authors:  Debra S Hausman; R Thomas Cambron; Adel Sakr
Journal:  Int J Pharm       Date:  2005-08-11       Impact factor: 5.875

10.  Influence of the pi-pi interaction on the hydrogen bonding capacity of stacked DNA/RNA bases.

Authors:  Pierre Mignon; Stefan Loverix; Jan Steyaert; Paul Geerlings
Journal:  Nucleic Acids Res       Date:  2005-03-23       Impact factor: 16.971

View more
  1 in total

1.  Interaction between favipiravir and hydroxychloroquine and their combined drug assessment: in silico investigations.

Authors:  Cemal Parlak; Özgür Alver; Cecil Naphtaly Moro Ouma; Lydia Rhyman; Ponnadurai Ramasami
Journal:  Chem Zvesti       Date:  2021-11-02       Impact factor: 2.146

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.